Status:
COMPLETED
Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Mycoses
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
This protocol describes a prospective, randomized study examining the safety and efficacy of Itraconazole for preventing fungal infections in patients with Chronic Granulomatous Disease (CGD). CGD is ...
Detailed Description
This protocol describes a prospective, randomized study examining the safety and efficacy of Itraconazole for preventing fungal infections in patients with Chronic Granulomatous Disease (CGD). CGD is ...
Eligibility Criteria
Documented chronic granulomatous disease more than 5 years of age.
No fungal infection within the past year.
Not currently on other antifungals or have taken other antifungals during the past 3 months.
Not currently on phenytoin or rifampin.
Negative pregnancy test within 2 weeks of starting protocol.
Key Trial Info
Start Date :
January 1 1991
Trial Type :
INTERVENTIONAL
End Date :
March 1 2001
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00001280
Start Date
January 1 1991
End Date
March 1 2001
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland, United States, 20892